Innovative treatment of heart arrhytmias

EBAMed is a Geneva-based medical device company active in the ambitious field of proton therapy. The company is developing a novel treat­­ment system to monitor and react to heart move­ment during cardiac radio­ablation proce­­dures. The aim is to reduce the volume of healthy heart exposed to more than 20 gray of protons/photons during cardiac radio ablation, thereby maxi­­mizing long-term safety for patients.

ReCatalyst Overview core sensing